Express Scripts (ESRX)

ESRX (NASDAQ:Health Services)
$74.21
neg -0.51
-0.68%
Today's Range: 74.09 - 74.87 | ESRX Avg Daily Volume: 4,843,200
Last Update: 08/28/14 - 11:06 AM EDT
Volume: 839,120
YTD Performance: 6.38%
Open: $74.61
Previous Close: $74.72
52 Week Range: $59.20 - $79.37
Oustanding Shares: 745,450,000
Market Cap: 55,968,386,000
6-Month Chart
TheStreet Ratings Grade for ESRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 12 12 12 13
Moderate Buy 2 2 2 2
Hold 4 4 4 4
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.53 1.53 1.53 1.50
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 33.07
Price Earnings Comparisons:
ESRX Sector Avg. S&P 500
33.07 33.70 28.96
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
5.76% 16.70% 64.62%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.90 1.31 0.32
Net Income 40.80 0.60 0.17
EPS 28.00 0.04 0.01
Earnings for ESRX:
EBITDA 6.00B
Revenue 104.10B
Average Earnings Estimates
Qtr (09/14) Qtr (12/14) FY (12/14) FY (12/15)
Average Estimate $1.29 $1.39 $4.88 $5.45
Number of Analysts 14 13 15 16
High Estimate $1.31 $1.41 $4.91 $5.60
Low Estimate $1.27 $1.37 $4.85 $5.30
Prior Year $1.08 $1.12 $4.33 $4.88
Growth Rate (Year over Year) 19.31% 24.11% 12.79% 11.63%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
How to counter the effects of a downtrending dollar.
This stock is a steady climber, and it's at a glaring entry point.

Who's Trimmed and Who's Out Real Money Pro($)

Today I reduced my exposure in the following stocks:
If you have confidence in Walgreen's management it seems the better choice.

Stocks That Flash a Warning Real Money Pro($)

Express Scripts, Loews, Facebook, Baidu, Clorox and Intel are red in an aggressively green market.
Bullish
Nov 16, 2012 | 8:01 AM EST
ESRX was upgraded to Buy from Neutral, Citigroup said. $62 price target. Compelling valuation and sell-off overdone. 
The slow, prolonged selloff continues, despite good fundamental news.
Even a very conservative scenario would provide for a very nice total return by next year.

Self-Medicating Real Money Pro($)

I bought more Express Scripts.
Bearish
Nov 07, 2012 | 9:04 AM EST
Shares of ESRX now seen reaching $60, Oppenheimer said. Estimates also lowered on utilization headwinds. Outperform rating.

Columnist Conversations

Kass:
Please pay special attention to Monitise update in my Diary.
Lang:
Many are seeing the mind-boggling move here again TWTR. Not too surprising, as the technicals have been quite...
I bought shares of IT provider Cognizant Technologies (CTSH) this morning on weakness in the low $45's. CTSH'...
This morning your shares of Bluetooth and other connectivity chip company CSR plc (CSRE) have jumped...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.